ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $51,000 | -66.2% | 4,100 | -62.9% | 0.00% | -60.0% |
| Q3 2016 | $151,000 | +139.7% | 11,063 | +29.6% | 0.01% | +150.0% |
| Q2 2016 | $63,000 | -89.6% | 8,534 | -91.0% | 0.00% | -88.6% |
| Q1 2016 | $605,000 | -35.8% | 94,715 | -37.1% | 0.04% | -36.4% |
| Q4 2015 | $942,000 | +2.4% | 150,676 | -4.4% | 0.06% | +17.0% |
| Q3 2015 | $920,000 | -36.5% | 157,606 | -10.0% | 0.05% | -33.8% |
| Q2 2015 | $1,449,000 | +354.2% | 175,200 | +352.1% | 0.07% | +343.8% |
| Q1 2015 | $319,000 | +184.8% | 38,750 | +138.4% | 0.02% | +166.7% |
| Q4 2014 | $112,000 | – | 16,257 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |